BRAF and melanoma: Paradoxically, the absence of endogenous MITF expression has also been be associated with MAPK inhibitor resistance (8), suggesting that either the excess or absence of MITF is permissive for cell viability under decreased MAPK signaling in BRAF-mutant melanoma.